TMCnet News
Nanobiotechnology - Global Strategic Business Report 2015-2022 - Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials - Research and MarketsResearch and Markets has announced the addition of the "Nanobiotechnology - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Nanobiotechnology in US$ Million. Companies Profiled:
Key Topics Covred: 1. INDUSTRY OVERVIEW 2. COMPETITIVE SCENARIO 3. MARKET DYNAMICS Developing Countries to Rise over the Horizon Nanomaterials & Nanoparticles Witness Robust Activity Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials Why Invest in Nanobiotechnology? Private and Public Companies to Step Up Funding on Nanotechnology United States Lead the Way in Government Funding Increasing Awareness on Technology to Drive Growth Demand for Novel Products to Push Up Growth Nano-Enabled Drug Discovery Holds Tremendous Potential Consolidation Sharpens the Industry's Edge 4. INDUSTRY CHALLENGES & ISSUES 5. INDUSTRY STRUCTURE 6. NANOBIO'S EPOCHAL STRIDES IN MODERN MEDICINE 7. INNOVATIONS & ADVANCEMENTS 8. CONCEPTUAL OVERVIEW 9. GLOBAL RESEARCH CENTERS AND INSTITUTIONS 10. RECENT INDUSTRY ACTIVITY Vectura Group Inks Merger Agreement with Skyepharma Flamel Technologies to Merge with Avadel Pharmaceuticals Pfizer to Acquire BIND Therapeutics Assets Janssen Sciences Ireland Enters into Collaboration with ViiV Healthcare Tekna Holdings Canada Inks Agreement with National Research Council of Canada Roche and BioMed X Sign a Collaboration Agreement Ablynx Enters into Exclusive Research Collaboration with Genzyme Pfizer Exercises Option to Develop and Commercialize Accurin BIND Therapeutics Inks Joint Research and Development Agreement with Merck 11. FOCUS ON (News - Alert) SELECT GLOBAL PLAYERS 12. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 79 The United States (49) Canada (2) Japan (1) Europe (19) - France (2) - Germany (6) - The United Kingdom (4) - Rest of Europe (7) Asia-Pacific (Excluding Japan) (5) Middle East (3) For more information about this report visit http://www.researchandmarkets.com/research/264zvd/nanobiotechnology View source version on businesswire.com: http://www.businesswire.com/news/home/20170217005566/en/ |